Commentary on Symptom Experience of Pulmonary Arterial Hypertension (PAH) Patients

被引:1
|
作者
Khan, Ehsan Ullah [1 ]
机构
[1] Kings Coll London, Florence Nightingale Sch Nursing & Midwifery, London SE1 8WA, England
关键词
pulmonary artery hypertension; PAH; breathlessness; PAH symptoms; QUALITY-OF-LIFE;
D O I
10.1177/1054773810395112
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Pulmonary arterial hypertension (PAH) is a complex and rapidly progressing illness with few long-term treatment options to prolong life and improve quality of life. The complexity of the disease predisposes patients to a multitude of symptoms that have an effect on their biopsychosocial well-being. McDonough et al. have taken a qualitative approach to examine the dimensions of PAH symptomology. Using a telephone survey approach, 10 patients were questioned regarding their symptoms. Following coding and categorization of the responses, two main themes were found, "holding back" and redefining life." The primary symptom associated with holding back was breathlessness. This symptom largely governed fears and behaviors associated with subthemes found within this main theme. Breathlessness also featured in the redefining life category; however, practical issues associated with medication and treatment were also assigned importance in this category by the study respondents. Symptoms of anxiety and depression were counteracted in many instances by a positive and sometimes stoic attitude toward the illness. This study presents important foundational information which will help direct further development of theoretical hypothesis related to PAH symptomology, as well as help focus clinical research toward venues that will enhance nursing care of this complex disease.
引用
收藏
页码:135 / 143
页数:9
相关论文
共 50 条
  • [31] Pulmonary Involvement in Systemic Sclerosis and Pulmonary Arterial Hypertension (PAH)
    Graefenstein, K.
    [J]. AKTUELLE RHEUMATOLOGIE, 2011, 36 (01) : 47 - 53
  • [32] Regional Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension (PAH)
    Winkler, T.
    Kohli, P.
    Kelly, V. J.
    Kehl, E. G.
    Kone, M. T.
    Hibbert, K.
    Rodriguez-Lopez, J. M.
    Systrom, D. M.
    Waxman, A. B.
    Venegas, J. G.
    Channick, R. N.
    Harris, R.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [33] Pulmonary Function and response to treatment in pulmonary arterial hypertension (PAH)
    Barbera, Joan Albert
    Galie, Nazzareno
    Frost, Adaani
    Ghofrani, Hossein Ardeschir
    Hoeper, Marius
    Mclaughlin, Vallerie
    Peacock, Andrew
    Simonneau, Gerald
    Vachiery, Jean-Luc
    Blair, Christiana
    Miller, Karen
    Harris, Julia
    Langley, Jonathan
    Rubin, Lewis
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [34] Macitentan real-world experience in elderly patients over 75 years with pulmonary arterial hypertension (PAH)
    Kim, N.
    Channick, R.
    Chin, K.
    Mitchell, L.
    Turricchia, S.
    Ong, R.
    Mclaughlin, V
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [35] Inhaled Treprostinil (it) In Management Of Pulmonary Arterial Hypertension (pah) - Experience In Central Valley Of California
    Ronaghi, R.
    Ghahremani-Ghajar, M.
    Voora, R.
    Balasubramanian, V.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [36] CLINICOPATHOLOGICAL CORRELATES IN 24 PATIENTS WITH ARDS AND PULMONARY ARTERIAL-HYPERTENSION (PAH)
    DIVERTIE, GD
    EDWARDS, WD
    DIVERTIE, MB
    OFFORD, KP
    MARSH, HM
    [J]. CHEST, 1986, 89 (06) : S454 - S454
  • [37] Cicletanine Therapy Is Well Tolerated in Patients with Advanced Pulmonary Arterial Hypertension (PAH)
    Waxman, A. B.
    Lawler, L.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [38] Sitaxsentan improves time to clinical worsening in patients with pulmonary arterial hypertension (PAH).
    Badesch, D
    Galie, N
    Langleben, D
    Naeije, R
    Simonneau, G
    Barst, RJ
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S167 - S167
  • [39] Sitaxsentan (STX) improves ventricular synchrony in patients with pulmonary arterial hypertension (PAH)
    Pulido, T.
    Namendys-Silva, S. A.
    Vallejo, E.
    Jimenez, L.
    Moreno-Sanchez, P.
    Rueda, T.
    Bautista, E.
    Sandoval, J.
    [J]. EUROPEAN HEART JOURNAL, 2006, 27 : 625 - 625
  • [40] Relationship between Race/Ethnicity and Survival in Patients with Pulmonary Arterial Hypertension (PAH)
    Medrek, S.
    Sahay, S.
    Kung, T.
    Zhao, C.
    Frost, A. E.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (04): : S96 - S96